✦ LIBER ✦

184 Can Point of Care Be as Good as the Central Lab?

✍ Scribed by W. Peacock; D. Diercks; J. Hollander; A. Singer; R. Birkhahn; N. Shapiro; W. Arnold; B. Noland; J. Nagurney

Book ID: 113454776
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 259 KB
Volume: 58
Category: Article
ISSN: 1097-6760
DOI: 10.1016/j.annemergmed.2011.06.212

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PROCLAMATION OF THE GOOD NEWS AS A PUBLI

PROCLAMATION OF THE GOOD NEWS AS A PUBLIC WITNESS — CAN IT BE AVOIDED?

✍ Jean Renneteau 📂 Article 📅 1983 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 339 KB

CAN AS GOOD RESULTS BE OBTAINED BY THE T

CAN AS GOOD RESULTS BE OBTAINED BY THE TREATMENT OF PULMONARY TUBERCULOSIS IN THE LOWLANDS AS AT HIGH ALTITUDES ?

✍ Saugman, Chr 📂 Article 📅 1912 🏛 The Lancet 🌐 English ⚖ 343 KB

Can a score derived from the Critical Ca

Can a score derived from the Critical Care Minimum Data Set be used as a marker of organ dysfunction? – a pilot study

✍ Tim W Felton; Rebecca Sander; Mo Al-Aloul; Paul Dark; Andrew M Bentley 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 410 KB

Unexperienced mechanical effects of musc

Unexperienced mechanical effects of muscular fatigue can be predicted by the Central Nervous System as revealed by anticipatory postural adjustments

✍ Monjo, Florian; Forestier, Nicolas 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 520 KB

Can prostate-specific antigen be used as

Can prostate-specific antigen be used as a valid end point to determine the efficacy of chemotherapy for advanced prostate cancer?

✍ B. Seckin; C. T. Anthony; B. Murphy; M. S. Steiner 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 444 KB

It is current practice in many clinical trials evaluating new chemotherapy regimens for the treatment of advanced prostate cancer to use prostate-specific antigen (PSA) decline as a response criteria with the assumption that the level of PSA reflects the efficacy of chemotherapy. Advanced prostate c

Can change in coronary lumen volume be u

Can change in coronary lumen volume be used as a more sensitive end-point in clinical trials of prevention of restenosis after coronary angioplasty? The PRESANCE study

✍ Y. Rosenberg; M. Lie`vre; P. Chirossel; J.P. Boissel 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 155 KB